Republicans hope to use study to withdraw abortion pill

Article

Two Republicans?Maryland Rep. Roscoe Bartlett and South Carolina Sen. Jim DeMint?are hoping that a report in the Annals of Pharmacotherapy will help spur support for companion bills that would require the withdrawal of Mifeprex, RU-486, from the market. Both bills would also require an investigation of the FDA's decision to approve the abortion drug.

Two Republicans-Maryland Rep. Roscoe Bartlett and South Carolina Sen. Jim DeMint-are hoping that a report in the Annals of Pharmacotherapy will help spur support for companion bills that would require the withdrawal of Mifeprex, RU-486, from the market. Both bills would also require an investigation of the FDA's decision to approve the abortion drug.

The December 2005 Annals report found that Mifeprex (mifepristone) caused 607 adverse events, including at least five deaths. Since the study ended in September 2004, a spokesperson for Bartlett noted that an additional 250 adverse events, including three deaths, have been reported. The adverse events include septic shock, severe bleeding, infection, unsuccessful termination of pregnancy, and fetal malformations.

"Today, we present stronger evidence that RU-486 kills and injures women," Bartlett told Drug Industry Daily Online (2/6/2006). "It is unacceptable for the FDA to expose women to the risk of serious injury, especially deadly infections whose symptoms are similar to any RU-486 abortion when we have documented cases of medical professionals who have failed to diagnose them."

Related Videos
The significance of the Supreme Court upholding mifepristone access | Image Credit: unchealth.org
One year out: Fezolinetant displays patient satisfaction for managing hot flashes | Image Credit: sutterhealth.org
Addressing maternal health inequities: Insights from CDC's Wanda Barfield | Image Credit: cdc.gov
Addressing racial and ethnic disparities in brachial plexus birth Injury | Image Credit: shrinerschildrens.org
Innovations in prenatal care: Insights from ACOG 2024 | Image Credit:  uofmhealth.org.
Unlocking therapeutic strategies for menopausal cognitive decline | Image Credit: uclahealth.org.
Navigating menopause care: Expert insights from ACOG 2024 | Image Credit: mayo.edu.
raanan meyer, md
© 2024 MJH Life Sciences

All rights reserved.